However, it should be noted that breast cancer cell-derived GM-CSF can polarize macrophages to promote immunosuppression and lung metastasis (56, 57) and increased GM-CSF has been observed in various tumor types (58), suggesting a requirement for developing context-dependent GM-CSF-targeting therapy. The gene discussed is CSF2; the disease is breast cancer.